SWK Holdings Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

SWK Holdings hat ein Gesamteigenkapital von $283.4M und eine Gesamtverschuldung von $31.2M, was einen Verschuldungsgrad von 11% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $321.3M bzw. $37.8M.

Wichtige Informationen

11.0%

Verhältnis von Schulden zu Eigenkapital

US$31.24m

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	US$20.82m
Eigenkapital	US$283.43m
Gesamtverbindlichkeiten	US$37.85m
Gesamtvermögen	US$321.28m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Shareholders May Be More Conservative With SWK Holdings Corporation's (NASDAQ:SWKH) CEO Compensation For Now

Jun 11

Update: SWK Holdings (NASDAQ:SWKH) Stock Gained 46% In The Last Five Years

Feb 16

Here's What SWK Holdings Corporation's (NASDAQ:SWKH) Shareholder Ownership Structure Looks Like

Jan 12

Enteris Biopharma sees growth opportunities in 2021 with potential partnerships in the works

Jan 07

SWK Holdings' subsidiary receives second milestone payment from Cara

Dec 24

A Look At SWK Holdings' (NASDAQ:SWKH) CEO Remuneration

Dec 08

SWK Holdings EPS beats by $0.40, beats on revenue

Nov 13

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: SWKHDie kurzfristigen Aktiva des Unternehmens ($287.5M) übersteigen seine kurzfristigen Passiva ($5.0M).

Langfristige Verbindlichkeiten: SWKHDie kurzfristigen Vermögenswerte des Unternehmens ($287.5M) übersteigen seine langfristigen Verbindlichkeiten ($32.9M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: SWKHDie Nettoverschuldung im Verhältnis zum Eigenkapital (3.7%) wird als zufriedenstellend angesehen.

Schulden abbauen: SWKHDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 0.06% auf 11% gestiegen.

Schuldendeckung: SWKHDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (70%).

Zinsdeckung: Unzureichende Daten, um zu bestimmen, ob die Zinszahlungen von SWKH für seine Schulden durch das EBIT gut gedeckt sind.

SWK Holdings Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

SWK Holdings: Baby Bond Represents Only Debt And 8.9% Coupon Yield

SWK Holdings Corporation Announces the Promotion of Courtney Baker to Controller

Price target decreased by 14% to US$22.00

SWK Holdings Corporation (NasdaqGM:SWKH) announces an Equity Buyback for $10 million worth of its shares.

New minor risk - Earnings quality

SWK Holdings Corporation, Annual General Meeting, Jun 14, 2024

SWK Holdings Offers Attractive 9% Baby Bond

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

SWK Holdings Corporation to Report Q3, 2023 Results on Nov 09, 2023

SWK Holdings Corporation to Report Q2, 2023 Results on Aug 09, 2023

SWK Holdings Corporation (NasdaqCM:SWKH) announces an Equity Buyback for $10 million worth of its shares.

Consensus EPS estimates increase by 20%

Consensus EPS estimates increase by 24%

High number of new and inexperienced directors

An unknown buyer acquired all shares in Harrow Health, Inc. from SWK Holdings Corporation (NasdaqCM:SWKH).

An unknown buyer acquired all shares in Harrow Health, Inc. from SWK Holdings Corporation (NasdaqCM:SWKH).

SWK Holdings Corporation Names Jody Staggs as Chief Executive Officer

High number of new and inexperienced directors

SWK Holdings Corporation to Report Q3, 2022 Results on Nov 10, 2022

Consensus revenue estimates increase by 15%

SWK Holdings unit receives $5M payment from Cara Therapeutics

SWK Holdings Corporation Promotes John David Tamas to Director of Underwriting

CEO & Chairman exercised options and sold US$475k worth of stock

SWK Holdings Corporation Announces Chief Executive Officer Changes

SWK Holdings announces leadership transition

Consensus revenue estimates fall by 17%

SWK Holdings Corporation to Report Q2, 2022 Results on Aug 11, 2022

SWK Holdings Corporation, Annual General Meeting, Jul 19, 2022

Consensus EPS estimates fall by 19%

High number of new and inexperienced directors

Killer R2K Setup In SWK

High number of new and inexperienced directors

SWK Holdings Corporation Announces Board and Committee Appointments

Carlson Capital, L.P. cancelled the acquisition of remaining 29% stake in SWK Holdings Corporation (NasdaqCM:SWKH).

CEO & Chairman exercised options and sold US$571k worth of stock

Funds managed by Carlson Capital, L.P. has made non-binding proposal to acquire remaining 29% stake in SWK Holdings Corporation.

SWK Holdings Corporation(NasdaqCM:SWKH) dropped from Russell 3000E Value Index

SWK Holdings Corporation (NasdaqCM:SWKH) announces an Equity Buyback for $5 million worth of its shares.

Cannell Capital Provides Information to the Shareholders

Shareholders May Be More Conservative With SWK Holdings Corporation's (NASDAQ:SWKH) CEO Compensation For Now

Consensus forecasts updated

New 90-day high: US$15.09

Update: SWK Holdings (NASDAQ:SWKH) Stock Gained 46% In The Last Five Years

Here's What SWK Holdings Corporation's (NASDAQ:SWKH) Shareholder Ownership Structure Looks Like

Enteris Biopharma sees growth opportunities in 2021 with potential partnerships in the works

SWK Holdings' subsidiary receives second milestone payment from Cara

New 90-day high: US$15.29

Market bids up stock over the past week

A Look At SWK Holdings' (NASDAQ:SWKH) CEO Remuneration

Market pulls back on stock over the past week

SWK Holdings EPS beats by $0.40, beats on revenue

New 90-day high: US$15.15

New 90-day high: US$15.05

New 90-day high - US$14.45

New 90-day high - US$14.22

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen